Bacteria found in the eye may offer new clues about inflammation, cognitive decline, and the progression of Alzheimer’s disease.

Dr. Maya Koronyo-Hamaoui, a professor of neurosurgery, neurology and biomedical sciences at Cedars-Sinai Health Sciences University, has found that Chlamydia pneumoniae, a common respiratory bacterium, may be linked to Alzheimer’s disease-related changes in the brain and retina. Her work, focusing on Alzheimer’s disease, neuroinflammation and retinal imaging, seeks to improve how neurodegenerative diseases are detected, monitored, and treated.

During this conversation with Being Patient’s Mark Niu, Koronyo-Hamaoui explained how her team found evidence of Chlamydia pneumoniae in eye and brain tissue, with higher bacterial burden associated with more severe Alzheimer’s disease. She also discussed how the retina may serve as a noninvasive window into brain health, why chronic inflammation may play a role in disease progression, and why future research is needed to understand whether infection may contribute to Alzheimer’s risk in some people.---If you loved listening to this Live Talk, visit our website to find more of our Alzheimer’s coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter:   / being_patient_  Instagram:   / beingpatientvoices  Facebook:   / beingpatientalzheimers  LinkedIn:   / being-patient  Being Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://beingpatient.com/live-talks/

Podden och tillhörande omslagsbild på den här sidan tillhör Being Patient. Innehållet i podden är skapat av Being Patient och inte av, eller tillsammans med, Poddtoppen.